Should you get genetic testing for breast cancer if a family member has been diagnosed?
Sometimes yes, but often no. A relative’s breast cancer diagnosis can raise questions about inherited risk, yet most breast cancers are not caused by an inherited gene mutation. Genetic testing is usually most useful when the family history follows certain patterns, such as several close relatives affected, diagnosis at a younger age, or cancers linked to genes such as BRCA1 and BRCA2. The right first step is usually a careful family history review and, where appropriate, referral for genetic counselling.
Pro Tip: If several closely related family members have had breast or ovarian cancer, consider consulting a genetics professional even if previous tests were negative.
Understanding genetic testing in the context of breast cancer
One family member with breast cancer does not automatically mean there is hereditary cancer in the family. Breast cancer is common, which means that some families will have more than one case by chance alone.
Genetic testing looks for inherited changes in certain genes that are known to raise the risk of breast cancer and, in some cases, ovarian or other cancers. BRCA1 and BRCA2 are the best known examples, but they are not the only breast cancer genes considered in current practice. NHS and NICE guidance support testing in people whose personal or family history suggests a meaningful chance of an inherited mutation.
A few distinctions make the picture clearer:
- Most breast cancer is not inherited.
- A gene mutation is different from a general risk factor such as age, weight, alcohol intake, or breast density.
- A positive test can show increased risk, but it cannot predict exactly if or when cancer will develop.
- A negative test does not always mean average risk, especially if the wider family history is strong.
Misunderstandings are common. Some people assume that genetic testing gives a simple yes or no answer about future cancer. Others think that a family history on the father’s side matters less than the mother’s side. Neither point is correct. Inherited risk can come through either side of the family, and test results need to be read in the context of the whole family pattern.
Request a Family History Assessment
Why family history matters, and when it does not?
Family history matters most when it suggests a pattern, not simply an isolated diagnosis. Clinicians usually pay closest attention to first-degree relatives, namely a mother, sister, daughter, or father, and to relatives diagnosed at a younger age.
A stronger signal may be present if several relatives have had breast cancer, if one person developed cancer in both breasts, or if breast and ovarian cancer appear in the same family. Early-onset cancer also changes the picture. A diagnosis in a relative in their thirties or forties may carry more weight than a diagnosis much later in life.
By contrast, one relative diagnosed at an older age does not always point to an inherited cause. A great-aunt diagnosed in later life may be less informative than a sister diagnosed young. Distance in the family tree matters, although it does not make a history irrelevant.
Paternal history is often overlooked. If breast cancer, ovarian cancer, or related cancers are present on your father’s side, that history still counts in a risk assessment. Genes are inherited from both parents.
In clinic, a family history review often includes details that people do not always expect to be relevant, such as ages at diagnosis, whether cancers occurred on the same side of the family, and whether any male relatives had breast cancer. Those details can shift a referral decision far more than the number of relatives alone.
Who should consider genetic testing after a family diagnosis?
Testing is generally considered for people whose personal or family history suggests a higher chance of an inherited gene mutation. That decision is usually made through NHS Genetics Services, a family history clinic, or a specialist team involved in breast care.
You may be more likely to be referred if one or more of the following applies:
- Several close relatives have had breast cancer, ovarian cancer, or both.
- A relative was diagnosed at a young age.
- A family member has had bilateral breast cancer.
- Male breast cancer has occurred in the family.
- A known gene mutation, such as BRCA1 or BRCA2, is already present in a relative.
- Your own diagnosis or family pattern fits NICE referral criteria for familial breast cancer.
Plenty of people with a family member affected by breast cancer will not meet criteria for testing. That does not mean concerns are being dismissed. It simply means the balance of evidence does not suggest that a gene test is likely to add useful information.
Specialist assessment matters here. A consultant breast surgeon, genetics clinician, or genetic counsellor may recommend testing, surveillance, or no testing at all, depending on the exact pattern. In some families, the most informative person to test first is the relative who has had cancer, because that can make later predictive testing in unaffected relatives far clearer.
Pro Tip: When attending your clinic appointment, bring detailed family information including ages at diagnosis and any cancers on both sides of the family.
What to expect from the genetic testing process?
Genetic testing is a process, not just a sample sent to a laboratory. Most people will first have a discussion about why testing is being considered and what different results may mean.
A typical pathway often looks like this:
- A clinician takes a detailed personal and family history and decides whether referral is appropriate.
- A genetics appointment covers pre-test counselling, consent, and the possible outcomes of testing.
- A blood sample or saliva sample is taken for laboratory analysis.
- Results are reviewed with a clinician or genetic counsellor, who explains what they do and do not mean.
- Follow-up planning is arranged, which may include screening advice, family discussion, or referral back to the breast team.
Turnaround times vary, and the result is not always straightforward. Some people receive a clearly positive result, meaning a known gene mutation has been found. Others receive a negative result. Another group receive a variant of uncertain significance, which means a genetic change has been found but its meaning is not yet clear.
That uncertain category can be difficult to interpret without support. A variant of uncertain significance usually does not lead to the same decisions as a proven harmful mutation. Genetics clinics and breast multidisciplinary teams are used to helping patients understand that distinction in plain language.
Risks, limitations, and common misconceptions
Genetic testing can be useful, but it can also bring uncertainty. A result may affect how someone thinks about their own health, their children, siblings, or future surgery. Even a result that looks reassuring at first glance may need careful explanation.
Several limitations are worth keeping in mind:
- A negative result does not always remove inherited risk.
- An uncertain result may not change treatment or screening plans.
- A positive result may raise difficult choices about surveillance or risk-reducing surgery.
- Emotional impact can be significant, especially in families already coping with a recent diagnosis.
- Test results do not measure all possible causes of breast cancer.
False reassurance is one of the commonest problems. Someone may hear “negative test” and assume there is no increased risk at all, even if the family history still suggests closer follow-up. The reverse can happen too. A positive BRCA test does not mean cancer is inevitable.
Insurance and privacy questions also come up. In the UK, rules and practice differ by type of insurance and by the context in which information is used, so it is sensible to ask for current guidance during counselling rather than rely on hearsay. NHS and genetic counselling services can explain the position in general terms.
Another misconception is that testing should automatically happen as soon as any relative is diagnosed. In practice, timing and choice of who gets tested first can affect how informative the result will be. A hurried test in the wrong person may answer less than people expect.
Arrange an Expert Surgical Opinion
Questions to ask your specialist before deciding
A short list of focused questions can make the discussion more useful. You do not need to ask all of them, but they can help organise the decision.
- Does my family history suggest inherited breast cancer, or is testing unlikely to change management?
- Am I the right person in the family to be tested first?
- Which genes are being looked at, and why those genes?
- What would a positive, negative, or uncertain result mean for me in practical terms?
- Would the result change screening, surgery, or treatment decisions?
- What might this mean for my children, siblings, or other relatives?
- How long are results likely to take?
- Who will explain the result to me, and what follow-up support is available?
Some people also want to ask how a result fits with current breast imaging, biopsy findings, or treatment planning after a new diagnosis. That is especially relevant if surgery is being discussed and inherited risk may affect the choice between breast conservation and mastectomy.
In more complex cases, a second opinion can help join the genetics picture with the surgical one. Practices such as D B Ghosh Breast Surgeon Specialist in Cancer and Cosmetic Surgery Harley Street London may be involved where patients want consultant-led discussion of breast cancer surgery, reconstruction, and inherited risk in the same overall plan.
Moving forward: genetic testing as one part of the bigger picture
A gene test can be informative, but it is only one tool in breast cancer risk management. Family history, age, personal medical history, imaging findings, biopsy results, and treatment goals all matter as well.
For someone without cancer, the main issue may be future screening or risk reduction. For someone newly diagnosed, the result may feed into surgical planning, timing, and discussion with the wider multidisciplinary team. The meaning of the same result can therefore differ from one person to another.
Consultant-led care is valuable because these decisions rarely sit neatly in one box. Genetic information may guide the next step, yet it does not replace careful clinical judgement. A thoughtful assessment keeps the test in proportion, which means that the result informs decisions instead of driving them on its own.
If a family member has been diagnosed, the most sensible response is usually to gather accurate family information, ask for a proper risk assessment, and treat genetic testing as a targeted option rather than an automatic one. That approach tends to produce clearer decisions, fewer assumptions, and a steadier path through an already difficult subject.
